Tourmaline Bio, Inc.

TRML · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$30,506$140,726$8,258$18,614
Short-Term Investments$227,797$62,225$0$225,357
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$10,539$5,923$54$2,543
Total Curr. Assets$268,842$208,874$8,312$246,514
Property Plant & Equip (Net)$267$447$570$4,804
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$36,633$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3,259$974$216$104
Total NC Assets$40,159$1,421$786$4,908
Other Assets$0$0$0$0
Total Assets$309,001$210,295$9,098$251,422
Liabilities
Payables$3,583$1,071$401$2,556
Short-Term Debt$227$221$162$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,099$3,710$800$5,431
Total Curr. Liab.$8,909$5,002$1,363$7,987
LT Debt$17$194$342$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$23$57$27,125$626
Total NC Liab.$40$251$27,467$626
Other Liabilities$0$0$0$0
Cap. Leases$244$415$504$0
Total Liabilities$8,949$5,253$28,830$8,613
Equity
Pref Stock$0$0$0$0
Common Stock$3$2$0$4
Retained Earnings-$135,261-$62,051-$19,927-$90,847
AOCI$296$67$0-$78
Other Equity$435,014$267,024$195$333,730
Total Equity$300,052$205,042-$19,732$242,809
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$309,001$210,295$9,098$251,422
Net Debt-$30,262-$140,311-$7,754-$18,614
Tourmaline Bio, Inc. (TRML) Financial Statements & Key Stats | AlphaPilot